Navigation Links
Ocular Pharma Company Charlesson Announces $2.35MM in New Funding
Date:10/17/2007

se, and we look forward to working with the FDA to initiate human clinical trials," said Mr. Moradi.

Charlesson also received $1,141,000 in a special request for proposals from the NIH to develop therapies to treat complications of type 1 diabetes. These funds will be used to develop Charlesson's gene therapy program to deliver DNA encoding CLT-001 to the retina. CLT-001 is a naturally occurring peptide found in the eye, and Charlesson has demonstrated that supplementation of this peptide in animal models of diabetes and AMD has profound effects on reducing neovascular and inflammatory events in the eye. In contrast to typical gene therapy where viral vectors are used to deliver the gene of interest, Charlesson's program employs biodegradable nanoparticles for gene delivery. This non-viral approach eliminates many of the safety concerns in eliciting an immune response following gene therapy. Additionally, Charlesson has demonstrated that topical delivery of nanoparticle-encapsulated CLT-001 DNA can result in gene transfer to retinal cells in the back of the eye. "Our scientists have demonstrated the safety and efficacy of CLT-001 and we are excited to advance our nanoparticle gene therapy efforts", said Mr. Moradi. "This delivery system is expected to allow topical delivery of therapeutics that produce a sustained effect in the eye, without the need for frequent dosing". Charlesson was also awarded $135,000 from OCAST to utilize this gene- delivery method for treating hereditary retinal degenerations, such as Leber's Congenital Amaurosis and Retinitis Pigmentosa. This seed money from OCAST will aid in the development of preclinical data to support future SBIR grant applications to the NIH and National Science Foundation.

"Charlesson is another in the growing list of advanced technology companies that are choosing Oklahoma as their home. The federal Small Business Innovation Research program is designed to support companies such as Charlesson. As a state,
'/>"/>

SOURCE Charlesson, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
2. Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated
3. India to benefit from pharma companies move
4. South Africa Wins landmark case against pharmaceutical giants
5. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
6. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
7. Pharma cos must forge Strategic alliances
8. Jharkhand Pharmacies Refuse To Sell Viagra
9. Setting up a new pharmaceutical industry in India
10. Medicis Pharmaceutical company enters pediatric market
11. Supply of Radiopharmaceuticals Hampered by Attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Nwe is the co-author of a new weight loss book ... the Ace Medical Weight Loss Center in Rock Hill, SC. ... the industry of weight loss, and how several fad diets ... television shows, however, she says the topic of obesity is ... basic laughs, which she believes impacts whether Americans view it ...
(Date:12/17/2014)... December 17, 2014 In its comprehensive ... and its Argus Claim Review division have recently identified ... most common ways savings are achieved on behalf of ... millions of dollars in savings to Argus each year, ... , As explained by Tom Doney, Cypress president and ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... one worrisome phenomenon is when an illness that originated in ... as zoonosis -- is not uncommon and keeps researchers on ... disease might make inroads into the human population. A ... the culprits in this case were guinea pigs. More specifically, ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... improve overall health, but a growing body of evidence shows ... review finds. In fact, the benefits were similar to ... researcher Paula Chu, a doctoral candidate at Harvard University,s Health ... trials, found that people randomly assigned to take yoga classes ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), ... a new study providing evidence on the impact of ... children. , Sufficient enough evidence already exists showing a ... juice drinks, with the onset of tooth decay. One ... listed as 100% fruit juice, meaning it is completely ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
... that one in five men in their 40s has ... year and that young black men are more likely than ... published in the September 15, 2008 issue of CANCER ... valuable information as experts discuss possible changes to prostate cancer ...
... chemical might lead to drug treatments for humans , , SUNDAY, ... of mice resistant to diet-induced obesity. , The findings ... in people. They also shed light on the brain circuitry ... energy (i.e., food) an animal takes in and how quickly ...
... leading provider of enterprise portal connectivity solutions, announced ... Health Centre and Dr. Jay Wallin of Mount ... the monthly educational series reThinking eHealth. The session, ... physicians share ways their facilities have improved provider ...
... second shot now recommended , , FRIDAY, Aug. 8 (HealthDay News) ... United States in 1995, medical experts hoped it would be ... of a child,s first birthday giving lifelong immunity. , Now, ... protection from a single immunization fades over time, and that ...
... of Miley Cyrus and,the Jonas Brothers will have more ... artists take the stage with other performers at Disney,s,Concert ... programs at City of Hope. It will be held ... Tickets for the concert will,be available Saturday, August 16 ...
... TORONTO, Aug. 8 /PRNewswire/ - IntelliPharmaCeutics is pleased ... this press release to,the Company, include IntelliPharmaCeutics Ltd. ... has been very active with drug development work ... in Toronto, Canada. We,presently have 34 staff employed ...
Cached Medicine News:Health News:1 in 5 young men has had recent prostate cancer test 2Health News:Scientists Create Mice Resistant to Obesity 2Health News:Scientists Create Mice Resistant to Obesity 3Health News:Give the Providers What They Want: Two Physicians Share Ways Their Facilities Have Improved Provider Satisfaction 2Health News:Give the Providers What They Want: Two Physicians Share Ways Their Facilities Have Improved Provider Satisfaction 3Health News:Give the Providers What They Want: Two Physicians Share Ways Their Facilities Have Improved Provider Satisfaction 4Health News:Chickenpox Protection: Get That Booster 2Health News:Chickenpox Protection: Get That Booster 3Health News:The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14 2Health News:The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14 3Health News:IntelliPharmaCeutics Provides Update on Activities 2Health News:IntelliPharmaCeutics Provides Update on Activities 3Health News:IntelliPharmaCeutics Provides Update on Activities 4
(Date:12/15/2014)... , December 15, 2014 Investor-Edge has ... ZGNX ), Eli Lilly and Company (NYSE: ... (NYSE: SNY ), and Novartis AG (NYSE: ... be accessed at: http://investor-edge.com/register . On Friday, ... 1.16%, the Dow Jones Industrial Average lost 1.79%, to finish ...
(Date:12/15/2014)... Dec. 15, 2014  Stephen Squires, CEO and founder ... Materials Corp (OTCQB:QTMM), will be speaking at the ... (RCQM) on December 16th, 2014. The RCQM launch continues ... in attracting top faculty and students and by inviting ... research. "We have a long association ...
(Date:12/15/2014)...  The Government of Ghana has endorsed ... (GBF) and Terumo BCT to respond to the emerging Ebola crisis ... long-term health system capacity to the citizens of Ghana ... Ebola Readiness and Resilience Initiative (GERRI) is a multi-agency effort designed ... the possible arrival of the Ebola epidemic , Provide new ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
... 14, 2010 VIVUS, Inc. (Nasdaq: VVUS ) ... effort to secure regulatory approval for QNEXA® in the U.S., ... (FDA) designed to address items in the FDA,s Complete Response ... announced that the Endocrine and Metabolic Division of the FDA ...
... Science, Inc. (OTC Bulletin Board: CBIS ) a ... to announce it has signed a lease for a new ... Colorado. The 6,600 sq. ft. core facility at 2422 S. ... offices, administrative personnel, as well as the Lab Division core ...
Cached Medicine Technology:VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 2VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 3Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 2Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 3
...
...
Rhoton Curettes, titanium, length 191 mm, straight....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Medicine Products: